Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT01216124
What this trial is testing

Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Local Advanced Breast Cancer
Fudan University
Not applicableLooking for participantsNCT05877859
What this trial is testing

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Who this might be right for
Breast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage III+1 more
Emory University 10
Not applicableLooking for participantsNCT07066189
What this trial is testing

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Who this might be right for
Triple Negative Breast Cancer
Yale University 160
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Not applicableUnknownNCT03756090
What this trial is testing

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerBreast DiseasesBreast Neoplasms
Zhejiang Cancer Hospital 100
Early research (Phase 1)Ended earlyNCT03579472
What this trial is testing

M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT01990209
What this trial is testing

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Who this might be right for
Metastatic Breast Cancer
SCRI Development Innovations, LLC 71
Testing effectiveness (Phase 2)UnknownNCT05681728
What this trial is testing

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 26
Large-scale testing (Phase 3)Looking for participantsNCT03671044
What this trial is testing

Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Jina Pharmaceuticals Inc. 657
Testing effectiveness (Phase 2)Ended earlyNCT04331067
What this trial is testing

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Washington University School of Medicine 15
Early research (Phase 1)Looking for participantsNCT05504707
What this trial is testing

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT02978495
What this trial is testing

Neoadjuvant Carboplatin in Triple Negative Breast Cancer

Who this might be right for
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
Barretos Cancer Hospital 154
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Looking for participantsNCT05528133
What this trial is testing

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 86
Large-scale testing (Phase 3)Not Yet RecruitingNCT07628504
What this trial is testing

Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations

Who this might be right for
Adjuvant Drug Therapy
Fudan University 420
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Looking for participantsNCT04481763
What this trial is testing

The Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

Who this might be right for
Triple-Negative Breast Cancer
Jiangxi Provincial Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06616987
What this trial is testing

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Yeon Hee Park 40
Not applicableApproved For MarketingNCT04320693
What this trial is testing

Expanded Access for IMMU-132

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
Gilead Sciences
Not applicableLooking for participantsNCT07073755
What this trial is testing

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Who this might be right for
Metastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital 200
Next Page